PT Pyridam Farma Tbk

IDX:PYFA.JK

288 (IDR) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) IDR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 702,067.616715,425.027630,530.236277,398.062247,114.773250,445.853223,002.49216,951.584217,843.921222,302.408192,555.731176,730.98151,094.461140,858.442132,000.542119,580.97386,643.01961,336.54639,639.626
Cost of Revenue 420,053.998464,580.401385,949.261113,507.729106,912.02999,342.30588,026.69681,635.8379,859.55880,959.31162,125.46461,056.24249,501.43151,083.37447,756.68341,214.79931,011.94121,095.59616,235.049
Gross Profit 282,013.617250,844.626244,580.975163,890.332140,202.743151,103.548134,975.794135,315.754137,984.363141,343.096130,430.267115,674.738101,593.0389,775.06884,243.85978,366.17455,631.07940,240.95123,404.577
Gross Profit Ratio 0.4020.3510.3880.5910.5670.6030.6050.6240.6330.6360.6770.6550.6720.6370.6380.6550.6420.6560.59
Reseach & Development Expenses 17,765.48711,280.066573.44205,645.019853.1882,306.1381,186.2023,180.1941,364.9913,257.5141,464.3520000000
General & Administrative Expenses 33,071.77827,121.00320,592.62911,888.34410,068.0768,700.0368,540.988,250.0119,498.8339,286.0866,351.14824,297.76931,093.39224,077.21319,170.91214,610.63910,170.9398,631.2276,484.857
Selling & Marketing Expenses 117,063.76699,281.16896,739.43761,387.85656,921.40370,431.72855,740.50465,561.17268,933.8276,158.54970,351.8582,478.963,495.03560,039.85858,244.04557,598.11441,299.68327,570.29914,126.565
SG&A 272,079.272126,402.171117,332.06673,276.19966,989.4879,131.76464,281.48473,811.18378,432.65385,444.63476,702.998106,776.66994,588.42784,117.07177,414.95772,208.75351,470.62336,201.52620,611.422
Other Expenses 127.774117,574.82975,562.81159,213.38362,292.80458,434.20859,251.34151,677.475-1,201.196-2,607.533-2,451.37833.386282.3771,228.1206.135-623.44460.247227.41157.755
Operating Expenses 289,716.985255,257.065193,468.32132,489.582129,282.284137,565.973123,532.825125,488.659127,435.192131,356.156118,252.075106,776.66994,588.42784,117.07177,414.95772,208.75351,470.62336,201.52620,611.422
Operating Income -7,703.368345,856.74851,895.39232,143.68715,281.15214,508.48412,062.65210,519.29810,135.50910,193.6048,499.9298,898.0697,004.6035,657.9976,828.9026,157.4224,160.4564,039.4252,793.155
Operating Income Ratio -0.0110.4830.0820.1160.0620.0580.0540.0480.0470.0460.0440.050.0460.040.0520.0510.0480.0660.07
Total Other Income Expenses Net -75,544.584-82,776.647-43,084.061-2,501.478-2,762.33-2,220.312-1,843.689-2,773.688-5,994.241-5,775.752-3,678.263-926.11480.773-20.22-1,398.676-2,511.502-1,536.012-1,216.37-848.093
Income Before Tax -83,247.952263,080.1018,811.33129,642.20912,518.82211,317.2649,599.2817,053.4074,554.9314,211.1888,499.9297,971.9557,085.3765,637.7775,430.2253,645.9192,624.4442,823.0551,945.062
Income Before Tax Ratio -0.1190.3680.0140.1070.0510.0450.0430.0330.0210.0190.0440.0450.0470.040.0410.030.030.0460.049
Income Tax Expense 1,978.526-12,391.913,332.3797,537.8453,176.1042,869.8162,471.8791,907.091,467.8271,550.1662,304.1292,663.7331,913.331,438.5741,657.2571,337.042880.9611,093.649616.639
Net Income -85,220.975275,241.315,478.94422,104.3649,342.7188,447.4487,127.4025,146.3173,087.1042,661.0226,195.85,308.2215,172.0464,199.2033,772.9682,308.8771,743.4841,729.4061,328.422
Net Income Ratio -0.1210.3850.0090.080.0380.0340.0320.0240.0140.0120.0320.030.0340.030.0290.0190.020.0280.034
EPS -34.2110.442.28.873.753.1613.329.625.775.5811.589.929.677.857.054.323.263.232.48
EPS Diluted -34.2110.442.28.873.753.1613.329.625.775.5811.589.929.677.857.054.323.263.232.48
EBITDA 49,742.641294,362.56958,699.20133,330.45215,281.69214,867.99514,192.60612,370.80712,404.67813,376.35114,408.5079,559.3277,352.2436,982.2747,393.445,453.874,556.0654,376.2112,803.295
EBITDA Ratio 0.0710.4110.0930.120.0620.0590.0640.0570.0570.060.0750.0540.0490.050.0560.0460.0530.0710.071